[老年人群中脚骨折的管理]
Thibault Favre1,2, Ardian Ramadani1,2, Diogo Vieira Cardoso1,2
1Service de chirurgie orthopédique et traumatologie de l'appareil moteur, Hôpitaux universitaires de Genève, 1211 Genève 14.
Revue medicale suisse
|December 18, 2025
概括
在老年人中管理脚骨折需要平衡稳定性与早期运动. 治疗选择,包括手术或保守护理,必须是个性化的,以保持独立性并最大限度地减少并发症.
科学领域:
- 整形外科手术 整形外科手术
- 老年医学 老年医学
- 创伤学 创伤学 创伤学
背景情况:
- 脚骨折在老年人群中很普遍.
- 同病症和功能衰退的风险使管理复杂化.
- 保持独立性和预防并发症是关键目标.
研究的目的:
- 审查当前对老年人脚骨折的管理策略.
- 强调早期动员的重要性.
- 讨论手术和保守的治疗选择.
主要方法:
- 对老年人骨骨折管理现有文献的综述.
- 分析手术技术 (ORIF,IM指甲,TT指甲) 和保守的方法.
- 强调基于骨折稳定性和患者因素的个性化治疗.
主要成果:
- 开放式减少和内部固定 (ORIF) 是不稳定的骨折的标准.
- 钉子固定技术 (五角形IM指甲,TT指甲) 为脆弱的患者提供了优势.
- 对于稳定的骨折或需求较低的患者,保守的治疗是可行的.
结论:
- 个性化治疗决策对于老年脚骨折至关重要.
- 管理层应优先考虑骨折稳定性和早期动员.
- 尽量减少发病率和保持患者的流动性是主要目标.
相关概念视频
Fractures: Bone Repair
4.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.9K
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
215
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
217
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175


